These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 20521322)

  • 1. Assessing the functional significance of ecstasy-related memory deficits using a virtual paradigm.
    Montgomery C; Hatton NP; Fisk JE; Ogden RS; Jansari A
    Hum Psychopharmacol; 2010; 25(4):318-25. PubMed ID: 20521322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electrophysiological evidence of atypical processing underlying mental set shifting in ecstasy polydrug and polydrug users.
    Roberts CA; Fairclough SH; McGlone FP; Fisk JE; Montgomery C
    Exp Clin Psychopharmacol; 2013 Dec; 21(6):507-15. PubMed ID: 24080019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MDMA polydrug users show process-specific central executive impairments coupled with impaired social and emotional judgement processes.
    Reay JL; Hamilton C; Kennedy DO; Scholey AB
    J Psychopharmacol; 2006 May; 20(3):385-8. PubMed ID: 16574712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for selective executive function deficits in ecstasy/polydrug users.
    Fisk JE; Montgomery C
    J Psychopharmacol; 2009 Jan; 23(1):40-50. PubMed ID: 18515461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Self-reports of executive dysfunction in current ecstasy/polydrug Users.
    Hadjiefthyvoulou F; Fisk JE; Montgomery C; Bridges N
    Cogn Behav Neurol; 2012 Sep; 25(3):128-38. PubMed ID: 22960437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ecstasy-related deficits in the updating component of executive processes.
    Montgomery C; Fisk JE
    Hum Psychopharmacol; 2008 Aug; 23(6):495-511. PubMed ID: 18512857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MDMA in humans: factors which affect the neuropsychobiological profiles of recreational ecstasy users, the integrative role of bioenergetic stress.
    Parrott AC
    J Psychopharmacol; 2006 Mar; 20(2):147-63. PubMed ID: 16510474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The confounding problem of polydrug use in recreational ecstasy/MDMA users: a brief overview.
    Gouzoulis-Mayfrank E; Daumann J
    J Psychopharmacol; 2006 Mar; 20(2):188-93. PubMed ID: 16510477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Self reported sleep quality and cognitive performance in ecstasy users.
    Montgomery C; Fisk JE; Wareing M; Murphy P
    Hum Psychopharmacol; 2007 Dec; 22(8):537-48. PubMed ID: 17960556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive function and mood in MDMA/THC users, THC users and non-drug using controls.
    Lamers CT; Bechara A; Rizzo M; Ramaekers JG
    J Psychopharmacol; 2006 Mar; 20(2):302-11. PubMed ID: 16510488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Visuospatial working memory impairment in current and previous ecstasy/polydrug users.
    Fisk JE; Montgomery C; Hadjiefthyvoulou F
    Hum Psychopharmacol; 2011; 26(4-5):313-21. PubMed ID: 22700465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive performance in recreational ecstasy polydrug users: a two-year follow-up study.
    de Sola Llopis S; Miguelez-Pan M; Peña-Casanova J; Poudevida S; Farré M; Pacifici R; Böhm P; Abanades S; Verdejo García A; Langohr K; Zuccaro P; de la Torre R
    J Psychopharmacol; 2008 Jul; 22(5):498-510. PubMed ID: 18208910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reasoning deficits in ecstasy (MDMA) polydrug users.
    Fisk JE; Montgomery C; Wareing M; Murphy PN
    Psychopharmacology (Berl); 2005 Sep; 181(3):550-9. PubMed ID: 16025320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cannabis-related deficits in real-world memory.
    Montgomery C; Seddon AL; Fisk JE; Murphy PN; Jansari A
    Hum Psychopharmacol; 2012 Mar; 27(2):217-25. PubMed ID: 22389086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug-related decrease in neuropsychological functions of abstinent drug users.
    van Holst RJ; Schilt T
    Curr Drug Abuse Rev; 2011 Mar; 4(1):42-56. PubMed ID: 21466500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Executive working memory deficits in abstinent ecstasy/MDMA users: a critical review.
    Murphy PN; Wareing M; Fisk JE; Montgomery C
    Neuropsychobiology; 2009; 60(3-4):159-75. PubMed ID: 19893333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Learning and memory deficits in ecstasy users and their neural correlates during a face-learning task.
    Roberts GM; Nestor L; Garavan H
    Brain Res; 2009 Oct; 1292():71-81. PubMed ID: 19631624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuropsychological evidence of a relatively selective profile of temporal dysfunction in drug-free MDMA ("ecstasy") polydrug users.
    Fox HC; McLean A; Turner JJ; Parrott AC; Rogers R; Sahakian BJ
    Psychopharmacology (Berl); 2002 Jul; 162(2):203-14. PubMed ID: 12110998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Depression, impulsiveness, sleep, and memory in past and present polydrug users of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy).
    Taurah L; Chandler C; Sanders G
    Psychopharmacology (Berl); 2014 Feb; 231(4):737-51. PubMed ID: 24114426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective memory functioning among ecstasy/polydrug users: evidence from the Cambridge Prospective Memory Test (CAMPROMPT).
    Hadjiefthyvoulou F; Fisk JE; Montgomery C; Bridges N
    Psychopharmacology (Berl); 2011 Jun; 215(4):761-74. PubMed ID: 21301817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.